Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved a generic government funding status notice from the page. The study details, contacts, and locations remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedThe record for NCT02988817 now includes posted results, with Results First Submitted on 2022-11-07 and Results First Posted on 2023-01-05, and a last update on 2023-08-01. The page’s results section updates the outcome data and status history.SummaryDifference0.3%

- Check71 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check78 days agoChange Detected- Added: Revision: v3.1.0 - Removed: Genetic and Rare Diseases Information Center resources: Ovarian cancer; Revision: v3.0.2SummaryDifference0.2%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.